Report on the first international symposium on self-testing for HIV: The legal, ethical, gender, human rights and public health implications of self-testing scale-up
Meeting report - Geneva, Switzerland. 8-9 April 2013
HIV self-testing (HIVST) allows people to test in private. It is part of national policy in some countries including Kenya, with others considering introduction. In 2011, two pilot studies were conducted providing HIVST to health-workers in Kenya, and to community members in Malawi. In 2012, sale of the over-the-counter (OTC) OraQuick® in-home HIV test was given FDA approval in USA. Uncertainties remain about the ethical/legal impact of HIVST on uptake of HTC and linkage to care, and effects on clients, their partners.
In April 2013, with support from Brocher Foundation, UNAIDS, LSTM and WHO hosted the first global HIVST consultation. 49 participants, across 14 countries and many disciplines met to discuss legal, ethical, gender, human rights and public health implications of HIVST scale-up. Prime objectives: review evidence, on-going studies and planned approaches; examine opportunities/concerns; define research agenda; and begin process of developing WHO guidance.